2022 New Style Diosmin - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore
2022 New Style Diosmin - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 60kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool and dry place, sealed and keep away from light.
Package material:drum
Package size:25kg/drum
Safety information: Not dangerous goods
Introduction
Ibutamoren mesylate, also named MK677, is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin. It has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces sustained increases in the plasma levels of these hormones without affecting cortisol levels.
Specification (in house standard)
|
Item |
Specification |
| Appearance | White to off-white powder |
| 1HNMR | Conforms to structure |
| LC-MS | [M-Methanesulfonicacid+H]+：(530.1-530.2) |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.10% |
| Heavy Metal | <10ppm |
| Purity by HPLC | ≥99.0% |
Product detail pictures:
Related Product Guide:
Our well-equipped facilities and superb good quality control throughout all stages of manufacturing enables us to guarantee total buyer gratification for 2022 New Style Diosmin - Ibutamoren mesylate 214962-40-0 Hormone and endocrine – Neore , The product will supply to all over the world, such as: Kazakhstan, Orlando, Porto, Our technical expertise, customer-friendly service, and specialized products make us/company name the first choice of customers and vendors. We are looking for your inquiry. Let's set up the cooperation right now!
By Janet from Dominica - 2017.10.13 10:47
Cooperate with you every time is very successful, very happy. Hope that we can have more cooperation!
By Sabrina from Estonia - 2018.09.29 17:23
